| scholarly article | Q13442814 |
| P2093 | author name string | Morimoto S | |
| Inoue T | |||
| Kitano S | |||
| Ogihara T | |||
| Fukuo K | |||
| Nakahashi T | |||
| Sasada R | |||
| Yasuda O | |||
| P2860 | cites work | Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor) | Q24634292 |
| Nitric oxide: physiology, pathophysiology, and pharmacology | Q26778243 | ||
| Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria | Q29616614 | ||
| Angiogenic factors | Q29620582 | ||
| Antimitogenic and mitogenic actions of interleukin-1 in diverse cell types are associated with induction of gro gene expression | Q30877961 | ||
| Cell proliferation in human coronary arteries | Q33635457 | ||
| Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages | Q33908328 | ||
| Nitric oxide mediates interleukin-1-induced cellular cytotoxicity in the rat ovary. A potential role for nitric oxide in the ovulatory process | Q33910931 | ||
| Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells | Q34237322 | ||
| Quantitation of mRNA by the polymerase chain reaction | Q34324828 | ||
| Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor | Q34617842 | ||
| Biochemistry of Nitric Oxide and Its Redox-Activated Forms | Q35159350 | ||
| Nitric oxide: first in a new class of neurotransmitters | Q35260638 | ||
| Molecular and biological properties of the vascular endothelial growth factor family of proteins | Q35313427 | ||
| Nitric oxide: a pathogenetic factor in autoimmunity | Q35330005 | ||
| Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries | Q35597553 | ||
| Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor | Q35609149 | ||
| Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids | Q35809793 | ||
| Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis | Q35830485 | ||
| Ultrastructure of the human aortic fibrolipid lesion. Formation of the atherosclerotic lipid-rich core | Q35836076 | ||
| Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery | Q35858039 | ||
| Regulation of macrophage functions by L-arginine | Q36356213 | ||
| Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine | Q36510258 | ||
| Angiogenesis in arteries: Review | Q36665512 | ||
| Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors | Q37138232 | ||
| Cloning of Inducible Nitric Oxide Synthase in Rat Vascular Smooth Muscle Cells | Q38321433 | ||
| Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. | Q38629840 | ||
| The pathogenesis of atherosclerosis--an update | Q39726917 | ||
| Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease | Q40488319 | ||
| Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor | Q41140209 | ||
| Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis | Q41543829 | ||
| Prostaglandin-induced apoptosis of ovarian surface epithelial cells | Q41557230 | ||
| Effects of prostaglandins on the cytosolic free calcium concentration in vascular smooth muscle cells | Q42216046 | ||
| Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules | Q42507922 | ||
| Aortic smooth muscle cells express and secrete vascular endothelial growth factor | Q43655025 | ||
| Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells | Q44942544 | ||
| Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. | Q45191938 | ||
| Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth | Q45849611 | ||
| Corpus luteum angiogenic factor is related to fibroblast growth factor | Q48430877 | ||
| Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells | Q48858920 | ||
| Balloon injury and interleukin-1 beta induce nitric oxide synthase activity in rat carotid arteries. | Q50791395 | ||
| The importance of hemorrhage in the relationship between gross morphologic characteristics and cerebral symptoms in 376 carotid artery plaques. | Q52216949 | ||
| Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor | Q54180410 | ||
| Release of nitric oxide from human vascular smooth muscle cells. | Q54286399 | ||
| Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor | Q56429774 | ||
| Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro | Q67466166 | ||
| Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human Atheroma | Q68352602 | ||
| Monoclonal antibodies against human basic fibroblast growth factor | Q69064443 | ||
| Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium | Q69639693 | ||
| Nitric oxide mediates interleukin-1-induced prostaglandin E2 production by vascular smooth muscle cells | Q70466078 | ||
| Carotid artery stenosis following endarterectomy | Q70504881 | ||
| Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation | Q70580552 | ||
| Nitric Oxide Synthase Induces Macrophage Death by Apoptosis | Q72075157 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| cytotoxicity | Q246181 | ||
| neovascularization | Q1281049 | ||
| P304 | page(s) | 669-676 | |
| P577 | publication date | 1995-02-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques | |
| P478 | volume | 95 |
| Q58492262 | Adventitial vasa vasorum in balloon-injured coronary arteries |
| Q30464012 | Alpha 2-macroglobulin functions as a cytokine carrier to induce nitric oxide synthesis and cause nitric oxide-dependent cytotoxicity in the RAW 264.7 macrophage cell line |
| Q43616390 | Altered arterial expression patterns of inducible and endothelial nitric oxide synthase in pulmonary plexogenic arteriopathy caused by congenital heart disease |
| Q36080082 | Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide |
| Q44027661 | Arachidonic acid release by cPLA2 may be causally related to NO-induced apoptosis in vascular smooth muscle cells |
| Q44388348 | Bacille Calmette-Guérin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-gamma). |
| Q79084821 | Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells |
| Q41074073 | Cell Injury-Induced Release of Fibroblast Growth Factor 2: Relevance to Intracerebral Mesenchymal Stromal Cell Transplantations |
| Q73204040 | Decreased nitric oxide production in chronic viral hepatitis B and C |
| Q38696421 | Effects of deoxynivalenol (DON) and its microbial biotransformation product deepoxy-deoxynivalenol (DOM-1) on a trout, pig, mouse, and human cell line |
| Q37380464 | Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. |
| Q40357672 | Exogenous nitric oxide stimulates cell proliferation via activation of a mitogen-activated protein kinase pathway in ovine fetoplacental artery endothelial cells |
| Q38992603 | Gelatin-siloxane nanoparticles to deliver nitric oxide for vascular cell regulation: synthesis, cytocompatibility, and cellular responses |
| Q41063368 | In vitro toxicity of sodium nitroprusside to human endothelial ECV304 cells |
| Q35767797 | Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide |
| Q42437905 | Inhibitory effects of ursodeoxycholic acid on the induction of nitric oxide synthase in vascular smooth muscle cells |
| Q41046704 | Modulation of nitric oxide, hydrogen peroxide and cytokine production in a clonal macrophage model by the trichothecene vomitoxin (deoxynivalenol). |
| Q36810804 | Nitric oxide deficiency in pulmonary hypertension: Pathobiology and implications for therapy |
| Q45856962 | Nitric oxide donor induces upregulation of stress proteins in cold ischemic rat hearts |
| Q36628207 | Nitric oxide function in atherosclerosis |
| Q35147610 | Nitric oxide in inflammatory bowel disease |
| Q33340603 | Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. |
| Q39789609 | Nitric oxide induces heat-shock protein 70 expression in vascular smooth muscle cells via activation of heat shock factor 1 |
| Q73199533 | Nitric oxide inhibits wounds collagen synthesis |
| Q35107563 | Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chick chorioallantoic membrane |
| Q37299480 | Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy |
| Q35721799 | Regulation of cell physiology and pathology by protein S-glutathionylation: lessons learned from the cardiovascular system. |
| Q41141445 | Regulation of inducible nitric oxide synthase expression in L6 rat skeletal muscle cells |
| Q26825677 | Signaling regulation of fetoplacental angiogenesis |
| Q77962064 | The contribution of inducible nitric oxide and cytomegalovirus to the stability of complex carotid plaque |
| Q58363813 | Upregulation of cAMP is a new functional signal pathway of Klotho in endothelial cells |
Search more.